Implementing an immunotherapy toxicity (IOTOX) GI service improves outcomes in patients with immune-mediated diarrhea and colitis.

J Cancer Res Clin Oncol · 2023 · PMC9803881 · PMID 36585982

Europe PMC DOI

hedged sentence

0.0590

closest p · 1.2× alpha

0.0590

boldest claim

The sentences

showed a trendp = 0.059so close (0.05 < p ≤ 0.1)

In addition, a Kaplan–Meier survival analysis curve stratified by the IOTOX GI variable and COX regression analysis showed a trend toward improved overall survival after initiation of the algorithm (HR 0.620 [95% CI 0.374–1.018] p = 0.059) (Fig. 2 B).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.